2017
DOI: 10.1016/j.ymthe.2017.08.018
|View full text |Cite
|
Sign up to set email alerts
|

AAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye

Abstract: Ocular gene therapy has evolved rapidly into the clinical realm due to promising pre-clinical proof-of-concept studies, recognition of the high unmet medical need of blinding disorders, and the excellent safety profile of the most commonly used vector system, the adeno-associated virus (AAV). With several trials exposing subjects to AAV, investigators independently report about cases with clinically evident inflammation in treated eyes despite the concept of ocular immune privilege. Here, we provide a detailed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

10
134
1
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 106 publications
(156 citation statements)
references
References 25 publications
10
134
1
1
Order By: Relevance
“…Surprisingly, the AAV8-GFP construct also demonstrated some non-negligible effects on disease phenotypes of SMA mice (Fig 3). While we cannot be certain as to why that is, we speculate that it may be related to possible effects on the immune system, similarly to previous reports for AAV8 vectors 40,41 . Seeing as SMA mice have an altered immune response 42,43 and that inflammation can display both protective and adverse systemic properties 44 , including the CNS 45 and muscle 46 , it is possible that an activated immune response results in acute and/or intermittent benefits in AAV8-treated SMA animals.…”
Section: Discussionsupporting
confidence: 82%
“…Surprisingly, the AAV8-GFP construct also demonstrated some non-negligible effects on disease phenotypes of SMA mice (Fig 3). While we cannot be certain as to why that is, we speculate that it may be related to possible effects on the immune system, similarly to previous reports for AAV8 vectors 40,41 . Seeing as SMA mice have an altered immune response 42,43 and that inflammation can display both protective and adverse systemic properties 44 , including the CNS 45 and muscle 46 , it is possible that an activated immune response results in acute and/or intermittent benefits in AAV8-treated SMA animals.…”
Section: Discussionsupporting
confidence: 82%
“…In non‐human primates, subretinal injection of AAV‐8 gene vectors triggers both the innate and the adaptive immune response (Reichel et al. ). In humans, cytotoxic T‐cells are found after subretinal injection of the same AAV‐gene vector when immunosuppression is stopped (Reichel et al.…”
Section: Discussionmentioning
confidence: 99%
“…In humans, cytotoxic T‐cells are found after subretinal injection of the same AAV‐gene vector when immunosuppression is stopped (Reichel et al. ). These findings emphasize that the idea of the eye as an immune‐privileged organ favoring ocular gene therapy needs to be reconsidered.…”
Section: Discussionmentioning
confidence: 99%
“…The primate-derived variant NHP#26 transduced the outer retina at greatly reduced titer. Increasingly, it is understood that immune response to high doses of AAV vectors represents a significant factor influencing the success of retinal and other gene therapies( 21, 22 ). This vector may enable safer gene therapies for retinal degeneration in patients as a result of the decreased vector load required for transgene expression and may reduce risk of vector-related toxicity or immunogenicity.…”
Section: Discussionmentioning
confidence: 99%